不要不诚实 发表于 2025-3-23 10:31:08
http://reply.papertrans.cn/43/4270/426959/426959_11.pngconduct 发表于 2025-3-23 13:59:34
Carolyn Richert Bair,Jennifer Grant Haworth aromatase inhibitors.International authorship.Many breast tumours are dependent upon oestrogen for their development and continued growth. Over the last 25 years hormone therapy has progressed from the irreversible destruction of endocrine glands to the use of drugs that reversibly suppress oestroghallow 发表于 2025-3-23 21:29:48
action by compounds interacting with oestrogen receptors (ERs; antioestrogens) and the inhibition of oestrogen synthesis by inhibitors of the enzyme, aromatase. Treatment with the antioestrogen, tamoxifen, has been an important therapeutic advance in breast cancer management for patients with ER-posadj忧郁的 发表于 2025-3-24 01:42:52
The Opportunity Agenda: A Reexamination of Postsecondary Reward and Opportunity,s, Rogers, Lipton, and Morrell, 2002). Specifically, middle-and upper-income families will likely respond to initiatives that refocus public resources toward individuals from lower-income families by working to secure additional resources that benefit their children and by identifying additional mec稀释前 发表于 2025-3-24 06:11:19
http://reply.papertrans.cn/43/4270/426959/426959_15.png使坚硬 发表于 2025-3-24 09:04:19
John A. Centraloped and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy..978-3-7643-7418-1Series ISSN 2296-6056 Series E-ISSN 2296-6064颠簸地移动 发表于 2025-3-24 10:52:52
http://reply.papertrans.cn/43/4270/426959/426959_17.pngcruise 发表于 2025-3-24 16:11:00
William G. Tierneyloped and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy..978-3-7643-7418-1Series ISSN 2296-6056 Series E-ISSN 2296-6064Arthr- 发表于 2025-3-24 22:35:08
Cheryl D. Lovell,Catherine Trouthloped and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy..978-3-7643-7418-1Series ISSN 2296-6056 Series E-ISSN 2296-6064Respond 发表于 2025-3-25 00:09:25
Crystal Reneé Hill,Bruce Thompsonloped and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy..978-3-7643-7418-1Series ISSN 2296-6056 Series E-ISSN 2296-6064